BenevolentAI S.A. (AMS: BAI)

Netherlands flag Netherlands · Delayed Price · Currency is EUR
0.778
-0.020 (-2.51%)
Sep 4, 2024, 11:37 AM CET
-27.29%
Market Cap 97.31M
Revenue (ttm) 8.45M
Net Income (ttm) -72.96M
Shares Out 121.94M
EPS (ttm) -0.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,132
Open 0.798
Previous Close 0.798
Day's Range 0.760 - 0.798
52-Week Range 0.460 - 2.660
Beta 1.07
Analysts n/a
Price Target n/a
Earnings Date Sep 20, 2024

About BenevolentAI

BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company’s development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, an oral brain penetrant CHK1 inhibitor under preclinical study for the treatment of Glioblastoma Multiforme; BEN-34712, a preclinical candidate for the ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 248
Stock Exchange Euronext Amsterdam
Ticker Symbol BAI
Full Company Profile

News

There is no news available yet.